175 related articles for article (PubMed ID: 37639334)
1. Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants.
Clarke JD; Judson SM; Tian DD; Kirby TO; Tanna RS; Matula-Péntek A; Horváth M; Layton ME; White JR; Cech NB; Thummel KE; McCune JS; Shen DD; Paine MF
Clin Transl Sci; 2023 Oct; 16(10):1779-1790. PubMed ID: 37639334
[TBL] [Abstract][Full Text] [Related]
2. Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (
Tian DD; Kellogg JJ; Okut N; Oberlies NH; Cech NB; Shen DD; McCune JS; Paine MF
Drug Metab Dispos; 2018 May; 46(5):552-560. PubMed ID: 29467215
[TBL] [Abstract][Full Text] [Related]
3. Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in Mice.
Oyanna VO; Bechtold BJ; Lynch KD; Ridge Call M; Graf TN; Oberlies NH; Clarke JD
Pharm Res; 2024 Mar; 41(3):557-566. PubMed ID: 38302834
[TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
Misaka S; Abe O; Sato H; Ono T; Shikama Y; Onoue S; Yabe H; Kimura J
Eur J Clin Pharmacol; 2018 May; 74(5):601-609. PubMed ID: 29368187
[TBL] [Abstract][Full Text] [Related]
5. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe O; Ono T; Sato H; Müller F; Ogata H; Miura I; Shikama Y; Yabe H; Onoue S; Fromm MF; Kimura J; Misaka S
Eur J Clin Pharmacol; 2018 Jun; 74(6):775-783. PubMed ID: 29480324
[TBL] [Abstract][Full Text] [Related]
6. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers.
Kim TE; Ha N; Kim Y; Kim H; Lee JW; Jeon JY; Kim MG
Drug Des Devel Ther; 2017; 11():1409-1416. PubMed ID: 28533679
[TBL] [Abstract][Full Text] [Related]
7. An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).
Albassam AA; Markowitz JS
Planta Med; 2017 Apr; 83(6):496-508. PubMed ID: 28118673
[TBL] [Abstract][Full Text] [Related]
8. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.
Lu H; Meng X; Li C; Sang S; Patten C; Sheng S; Hong J; Bai N; Winnik B; Ho CT; Yang CS
Drug Metab Dispos; 2003 Apr; 31(4):452-61. PubMed ID: 12642472
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities.
Satoh T; Fujisawa H; Nakamura A; Takahashi N; Watanabe K
J Pharm Pharm Sci; 2016; 19(2):188-97. PubMed ID: 27518169
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
12. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
13. Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG).
Lorenz M; Rauhut F; Hofer C; Gwosc S; Müller E; Praeger D; Zimmermann BF; Wernecke KD; Baumann G; Stangl K; Stangl V
Sci Rep; 2017 May; 7(1):2279. PubMed ID: 28536463
[TBL] [Abstract][Full Text] [Related]
14. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
15. Absorption and pharmacokinetics of green tea catechins in beagles.
Mata-Bilbao Mde L; Andrés-Lacueva C; Roura E; Jáuregui O; Escribano E; Torre C; Lamuela-Raventós RM
Br J Nutr; 2008 Sep; 100(3):496-502. PubMed ID: 18205995
[TBL] [Abstract][Full Text] [Related]
16. Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin.
Huang S; Xu Q; Liu L; Bian Y; Zhang S; Huang C; Miao L
Curr Drug Metab; 2020; 21(6):471-478. PubMed ID: 32407265
[TBL] [Abstract][Full Text] [Related]
17. Impact of intestinal glucuronidation on the pharmacokinetics of raloxifene.
Kosaka K; Sakai N; Endo Y; Fukuhara Y; Tsuda-Tsukimoto M; Ohtsuka T; Kino I; Tanimoto T; Takeba N; Takahashi M; Kume T
Drug Metab Dispos; 2011 Sep; 39(9):1495-502. PubMed ID: 21646435
[TBL] [Abstract][Full Text] [Related]
18. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
19. Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols.
Révész K; Tütto A; Margittai E; Bánhegyi G; Magyar JE; Mandl J; Csala M
Int J Biochem Cell Biol; 2007; 39(5):922-30. PubMed ID: 17317271
[TBL] [Abstract][Full Text] [Related]
20. Polyphenol content of plasma and litter after the oral administration of green tea and tea polyphenols in chickens.
Zhou YB; Wan XC; Shang YY; Hu JW; Shao L; Chen W; Li DX
J Agric Food Chem; 2012 Feb; 60(7):1619-27. PubMed ID: 22224899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
